BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND CDKN1B, CDKN4, 1027, ENSG00000111276, MEN4, P27KIP1, P46527, MEN1B, KIP1 AND Prognosis
18 results:

  • 1. MicroRNA-147b induces neuroendocrine differentiation of prostate cancer cells by targeting ribosomal protein RPS15A.
    Natani S; Ramakrishna M; Nallavolu T; Ummanni R
    Prostate; 2023 Jul; 83(10):936-949. PubMed ID: 37069746
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. miR-196a-mediated downregulation of p27
    Zhan B; Huang L; Chen Y; Ye W; Li J; Chen J; Yang S; Jiang W
    Prostate; 2020 Sep; 80(12):1024-1037. PubMed ID: 32628792
    [TBL] [Abstract] [Full Text] [Related]  

  • 3.
    Faisal FA; Murali S; Kaur H; Vidotto T; Guedes LB; Salles DC; Kothari V; Tosoian JJ; Han S; Hovelson DH; Hu K; Spratt DE; Baras AS; Tomlins SA; Schaeffer EM; Lotan TL
    Clin Cancer Res; 2020 Jun; 26(11):2595-2602. PubMed ID: 31969336
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Upregulation of miR-130b Contributes to Risk of Poor prognosis and Racial Disparity in African-American prostate cancer.
    Hashimoto Y; Shiina M; Dasgupta P; Kulkarni P; Kato T; Wong RK; Tanaka Y; Shahryari V; Maekawa S; Yamamura S; Saini S; Deng G; Tabatabai ZL; Majid S; Dahiya R
    Cancer Prev Res (Phila); 2019 Sep; 12(9):585-598. PubMed ID: 31266828
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic Factors of prostate cancer in Tunisian Men: Immunohistochemical Study.
    Missaoui N; Abdelkarim SB; Mokni M; Hmissa S
    Asian Pac J Cancer Prev; 2016; 17(5):2655. PubMed ID: 27268646
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. miR-24 regulates cdkn1b/p27 expression in prostate cancer.
    Lynch SM; McKenna MM; Walsh CP; McKenna DJ
    Prostate; 2016 May; 76(7):637-48. PubMed ID: 26847530
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The role of high cell density in the promotion of neuroendocrine transdifferentiation of prostate cancer cells.
    Pernicová Z; Slabáková E; Fedr R; Šimečková Š; Jaroš J; Suchánková T; Bouchal J; Kharaishvili G; Král M; Kozubík A; Souček K
    Mol Cancer; 2014 May; 13():113. PubMed ID: 24884804
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Translation initiation factor eIF3b expression in human cancer and its role in tumor growth and lung colonization.
    Wang H; Ru Y; Sanchez-Carbayo M; Wang X; Kieft JS; Theodorescu D
    Clin Cancer Res; 2013 Jun; 19(11):2850-60. PubMed ID: 23575475
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Downregulation of both p21/Cip1 and p27/kip1 produces a more aggressive prostate cancer phenotype.
    Roy S; Singh RP; Agarwal C; Siriwardana S; Sclafani R; Agarwal R
    Cell Cycle; 2008 Jun; 7(12):1828-35. PubMed ID: 18583941
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A molecularly genetic determination of prognostic factors of the prostate cancer and their relationships to expression of protein p27kip1.
    Dvorácková J; Uvírová M
    Neoplasma; 2007; 54(2):149-54. PubMed ID: 17319789
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Expression of the ubiquitin ligase subunit cyclin kinase subunit 1 and its relationship to S-phase kinase protein 2 and p27kip1 in prostate cancer.
    Shapira M; Ben-Izhak O; Slotky M; Goldin O; Lahav-Baratz S; Hershko DD
    J Urol; 2006 Nov; 176(5):2285-9. PubMed ID: 17070313
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Molecular markers of prostate cancer outcome.
    Quinn DI; Henshall SM; Sutherland RL
    Eur J Cancer; 2005 Apr; 41(6):858-87. PubMed ID: 15808955
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The significance of key regulators of apoptosis in the development and prognosis of prostate carcinoma. II. Products of suppressor genes Rb and PTEN, CDKI, Fas.
    Knillová J; Kolár Z; Hlobilková A
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2003 Nov; 147(1):11-7. PubMed ID: 15034600
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Inadequate formalin fixation decreases reliability of p27 immunohistochemical staining: probing optimal fixation time using high-density tissue microarrays.
    De Marzo AM; Fedor HH; Gage WR; Rubin MA
    Hum Pathol; 2002 Jul; 33(7):756-60. PubMed ID: 12196928
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Predictive value of altered p27kip1 and p21WAF/Cip1 protein expression for the clinical prognosis of patients with localized prostate cancer.
    Kuczyk MA; Bokemeyer C; Hartmann J; Schubach J; Walter C; Machtens S; Knuchel R; Kollmannsberger C; Jonas U; Serth J
    Oncol Rep; 2001; 8(6):1401-7. PubMed ID: 11605074
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Levels of expression of p27kip1 protein in human prostate and prostate cancer: an immunohistochemical analysis.
    Erdamar S; Yang G; Harper JW; Lu X; Kattan MW; Thompson TC; Wheeler TM
    Mod Pathol; 1999 Aug; 12(8):751-5. PubMed ID: 10463475
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer.
    Masciullo V; Sgambato A; Pacilio C; Pucci B; Ferrandina G; Palazzo J; Carbone A; Cittadini A; Mancuso S; Scambia G; Giordano A
    Cancer Res; 1999 Aug; 59(15):3790-4. PubMed ID: 10446997
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. p27(kip1) acts as a downstream effector of and is coexpressed with the beta1C integrin in prostatic adenocarcinoma.
    Fornaro M; Tallini G; Zheng DQ; Flanagan WM; Manzotti M; Languino LR
    J Clin Invest; 1999 Feb; 103(3):321-9. PubMed ID: 9927492
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.